Exclusive Financial Adviser to Arcadian Risk Capital

Oppenheimer October 13, 2025
Oppenheimer’s European Insurance Investment Banking Team is pleased to have acted as Exclusive Financial Adviser to Arcadian Risk Capital on its Strategic Partnership with funds managed by Lee Equity Partners, LLC

On October 6, 2025 – Arcadian Risk Capital (“Arcadian” or the “Company”), a global specialty managing general agent (“MGA”), announced that it has entered into a strategic partnership (the “Transaction”) with funds managed by Lee Equity Partners, LLC (“Lee Equity”), a middle-market investment firm specialising in investments in the financial and healthcare services sectors. Oppenheimer Europe Ltd. acted as exclusive financial adviser to Arcadian. Following the Transaction, Arcadian’s management team and employees will maintain a significant ownership stake in the Company, while SiriusPoint, a minority investor in Arcadian, will sell all its 49% ownership stake. The parties will maintain a close commercial partnership as SiriusPoint renewed and extended its capacity agreement with Arcadian until 2031.

“This marks an important milestone for the Company. Lee Equity brings deep sector experience and shares our long-term view of building a disciplined, underwriting-led business. Their investment will allow us to accelerate, grow our platform, continue to attract world-class underwriters, and deepen our relationships that have supported our growth.”
John Boylan, Founder & CEO of Arcadian

The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions, including regulatory approvals.

This transaction reinforces Oppenheimer’s position as a leading M&A adviser within the insurance market and strengthens its international recognition in the sector. It follows a series of advisory engagements, including advising Saudi Reinsurance Company on the sale of its stake in Probitas Holdings (Bermuda) Limited to Aviva Insurance Limited; Carbon Underwriting on its minority investment from Apiary; BDB Holdings Ltd on its sale to Brown & Brown, Inc.; QBE on the sale of selected Irish commercial insurance portfolios to Ascot Group; and Agora on its sale to IQUW.


Arcadian Risk Capital is a global specialty MGA offering underwriting-led solutions for complex risks. They are client-focused, with a team of dedicated and highly experienced underwriters who have consistently demonstrated the ability to build and manage portfolios of risk throughout the insurance cycle. Innovation and client service are at the core of our business model. Founded and led by John Boylan, Arcadian is headquartered in Bermuda, with operating entities in Bermuda, Ireland, the United Kingdom, and the United States.

SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, they are listed on the New York Stock Exchange (SPNT). SiriusPoint has licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Their offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents and Program Administrators. With approximately $2.8 billion total capital, SiriusPoint’s operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch, and A3 from Moody’s. 

Lee Equity Partners, LLC is a middle-market private equity firm that partners with companies in the financial and healthcare services sectors. Over nearly two decades the firm has utilized its thematic based investment strategy and deep sector knowledge to identify and partner with talented management teams to accelerate growth and build market leading businesses.

Name:

Philippe Jacquemard

Title:

Managing Director, Head of Insurance EMEA

Name:

David Cariati

Title:

Associate

Name:

Toby Fuller

Title:

Analyst

Oppenheimer Europe Ltd.
 125 Wood Street, London EC2V 7AN, United Kingdom

DISCLOSURES

Oppenheimer Europe Ltd. is authorised and regulated by the Financial Conduct Authority.  8471263.1
 
 This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
 
 This notice may contain statistical data cited from third-party sources believed to be reliable, but neither Oppenheimer & Co. Inc. nor Oppenheimer Europe Ltd. represents that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.